Therapeutic efficacy of ruxolitinib combined with low-dose hormone in aGVHD after allogeneic hematopoietic stem cell transplantation

[Objective] To evaluate the efficacy and safety of ruxolitinib combined with low-dose hormone for patients with acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). [Methods] Thirty patients with aGVHD after allo-HSCT admitted to the Departmen...

Cijeli opis

Bibliografski detalji

Glavni autori:	HU Yue, ZHANG Xupai, LAI Sihan, ZHANG Shan, MA Lei, WANG Xiao, DENG Yan, HAN Ying, HE Ying, HE Guangcui, YI Hai
Format:	Artigo
Jezik:	Chinês
Izdano:	Institute of Blood Transfusion of Chinese Academy of Medical Sciences 2026-04-01
Serija:	Zhongguo shuxue zazhi
Teme:	ruxolitinib glucocorticoid allogeneic hematopoietic stem cell transplantation (allo-hsct) acute graft versus host disease (agvhd)
Online pristup:	https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2026.04.013&lang=en
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!